Published on 23 Feb 2024 on Simply Wall St. via Yahoo Finance
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shareholders are probably feeling a little disappointed, since its shares fell 4.1% to US$44.55 in the week after its latest full-year results. It looks like a moderately negative result overall with revenues falling 14% short of analyst estimates at US$23m. Statutory losses were US$1.96 per share, roughly in line with what the analysts expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on IDEAYA Biosciences after the latest results.
See our latest analysis for IDEAYA Biosciences
